<DOC>
	<DOCNO>NCT00148421</DOCNO>
	<brief_summary>Comparing two drug treat subject non-myeloid malignancy receive multicycle chemotherapy .</brief_summary>
	<brief_title>Study Treatment Anemia Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy .</brief_title>
	<detailed_description>The purpose study compare effect darbepoetin alfa Epoetin alfa treatment anemia subject non-myeloid malignancy receive multicycle chemotherapy .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Planned chemotherapy treatment Anemia ( hemoglobin concentration less equal 11.0 g/dL ) Adequate renal liver function Subjects must provide write informed consent Known history seizure disorder Known primary hematologic disorder cause anemia nonmyeloid malignancy Unstable / uncontrolled cardiac condition Clinically significant inflammatory disease Known positive test HIV infection Neutralizing antibody rHuEPO Epoetin alfa darbepoetin alfa therapy within 4 week randomization Received investigational drug device within 30 day randomization Pregnant breast feed Not use adequate contraceptive precaution Previously randomize study Known hypersensitivity recombinant mammalianderived product Concerns subject 's compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Non-myeloid malignancy</keyword>
	<keyword>Chemotherapy-induced anemia</keyword>
</DOC>